메뉴 건너뛰기




Volumn 3, Issue 8, 2004, Pages 921-932

Preclinical validation of anti-TMEFF2-auristatin E-conjugated antibodies in the treatment of prostate cancer

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY CONJUGATE; AURISTATIN E MONOCLONAL ANTIBODY PR1 CONJUGATE; CATHEPSIN B; CITRULLINE; EPIDERMAL GROWTH FACTOR; FOLLISTATIN; PLASMA PROTEIN; TOMOREGULIN; TUMOR ANTIGEN; UNCLASSIFIED DRUG; VALINE;

EID: 4444297534     PISSN: 15357163     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (75)

References (41)
  • 1
    • 0036097509 scopus 로고    scopus 로고
    • Outcome predictions for patients with metastatic prostate cancer
    • Smaletz O, Scher HI. Outcome predictions for patients with metastatic prostate cancer. Semin Urol Oncol 2002;20:155-63.
    • (2002) Semin. Urol. Oncol. , vol.20 , pp. 155-163
    • Smaletz, O.1    Scher, H.I.2
  • 3
    • 0242407666 scopus 로고    scopus 로고
    • Weekly paclitaxel, estramustine phosphate, and oral etoposide in the treatment of hormone-refractory prostate carcinoma: Results of a Minnie Pearl Cancer Research Network phase II trial
    • Meluch AA, Greco FA, Morrissey LH, et al. Weekly paclitaxel, estramustine phosphate, and oral etoposide in the treatment of hormone-refractory prostate carcinoma: results of a Minnie Pearl Cancer Research Network phase II trial. Cancer 2003;98:2192-8.
    • (2003) Cancer , vol.98 , pp. 2192-2198
    • Meluch, A.A.1    Greco, F.A.2    Morrissey, L.H.3
  • 4
    • 0036671675 scopus 로고    scopus 로고
    • Chemotherapy for androgen-independent prostate cancer
    • Petrylak DP. Chemotherapy for androgen-independent prostate cancer. Semin Urol Oncol 2002;20:31-5.
    • (2002) Semin. Urol. Oncol. , vol.20 , pp. 31-35
    • Petrylak, D.P.1
  • 5
    • 12244302200 scopus 로고    scopus 로고
    • Role of chemotherapy in hormone-refractory prostate cancer. Old issues, recent advances and new perspectives
    • Autorino R, Di Lorenzo G, Damiano R, De Placido S, D'Armiento M. Role of chemotherapy in hormone-refractory prostate cancer. Old issues, recent advances and new perspectives. Urol Int 2003;70:1-14.
    • (2003) Urol. Int. , vol.70 , pp. 1-14
    • Autorino, R.1    Di Lorenzo, G.2    Damiano, R.3    De Placido, S.4    D'Armiento, M.5
  • 6
    • 0025027766 scopus 로고
    • Antitumor activity of Adriamycin (hydrazone-linked) immunoconjugates compared with free Adriamycin and specificity of tumor cell killing
    • Braslawsky GR, Edson MA, Pearce W, Kaneko T, Greenfield RS. Antitumor activity of Adriamycin (hydrazone-linked) immunoconjugates compared with free Adriamycin and specificity of tumor cell killing. Cancer Res 1990;50:6608-14.
    • (1990) Cancer Res. , vol.50 , pp. 6608-6614
    • Braslawsky, G.R.1    Edson, M.A.2    Pearce, W.3    Kaneko, T.4    Greenfield, R.S.5
  • 7
    • 0034050268 scopus 로고    scopus 로고
    • Monoclonal antibodies to the myeloid stem cells: Therapeutic implications of CMA-676, a humanized anti-CD33 antibody calicheamicin conjugate
    • Bernstein ID. Monoclonal antibodies to the myeloid stem cells: therapeutic implications of CMA-676, a humanized anti-CD33 antibody calicheamicin conjugate. Leukemia 2000;14:474-5.
    • (2000) Leukemia , vol.14 , pp. 474-475
    • Bernstein, I.D.1
  • 8
    • 0141919559 scopus 로고    scopus 로고
    • E-selectin up-regulation allows for targeted drug delivery in prostate cancer
    • Bhaskar V, Law DA, Ibsen E, et al. E-selectin up-regulation allows for targeted drug delivery in prostate cancer. Cancer Res 2003;63: 6387-94.
    • (2003) Cancer Res. , vol.63 , pp. 6387-6394
    • Bhaskar, V.1    Law, D.A.2    Ibsen, E.3
  • 9
    • 10744222473 scopus 로고    scopus 로고
    • Development of potent monoclonal antibody auristatin conjugates for cancer therapy
    • Doronina SO, Toki BE, Torgov MY, et al. Development of potent monoclonal antibody auristatin conjugates for cancer therapy. Nat Biotechnol 2003;21:778-84.
    • (2003) Nat. Biotechnol. , vol.21 , pp. 778-784
    • Doronina, S.O.1    Toki, B.E.2    Torgov, M.Y.3
  • 10
    • 0042738861 scopus 로고    scopus 로고
    • cAC10-vcMMAE, an anti-CD30-monomethyl auristatin E conjugate with potent and selective antitumor activity
    • Francisco JA, Cerveny CG, Meyer DL, et al. cAC10-vcMMAE, an anti-CD30-monomethyl auristatin E conjugate with potent and selective antitumor activity. Blood 2003;102:1458-65.
    • (2003) Blood , vol.102 , pp. 1458-1465
    • Francisco, J.A.1    Cerveny, C.G.2    Meyer, D.L.3
  • 11
    • 9444235053 scopus 로고    scopus 로고
    • Eradication of large colon tumor xenografts by targeted delivery of maytansinoids
    • Liu C, Tadayoni BM, Bourret LA, et al. Eradication of large colon tumor xenografts by targeted delivery of maytansinoids. Proc Natl Acad Sci USA 1996;93:8618-23.
    • (1996) Proc. Natl. Acad. Sci. USA , vol.93 , pp. 8618-8623
    • Liu, C.1    Tadayoni, B.M.2    Bourret, L.A.3
  • 12
    • 0036569591 scopus 로고    scopus 로고
    • Prostate stem cell antigen as therapy target: Tissue expression and in vivo efficacy of an immunoconjugate
    • Ross S, Spencer SD, Holcomb I, et al. Prostate stem cell antigen as therapy target: tissue expression and in vivo efficacy of an immunoconjugate. Cancer Res 2002;62:2546-53.
    • (2002) Cancer Res. , vol.62 , pp. 2546-2553
    • Ross, S.1    Spencer, S.D.2    Holcomb, I.3
  • 13
    • 0037440038 scopus 로고    scopus 로고
    • Cantuzumab mertansine, a maytansinoid immunoconjugate directed to the CanAg antigen: A phase I, pharmacokinetic, and biologic correlative study
    • Tolcher AW, Ochoa L, Hammond LA, et al. Cantuzumab mertansine, a maytansinoid immunoconjugate directed to the CanAg antigen: a phase I, pharmacokinetic, and biologic correlative study. J Clin Oncol 2003;21:211-22.
    • (2003) J. Clin. Oncol. , vol.21 , pp. 211-222
    • Tolcher, A.W.1    Ochoa, L.2    Hammond, L.A.3
  • 15
    • 0033589283 scopus 로고    scopus 로고
    • Hormone therapy failure in human prostate cancer: Analysis by complementary DNA and tissue microarrays
    • Bubendorf L, Kolmer M, Kononen J, et al. Hormone therapy failure in human prostate cancer: analysis by complementary DNA and tissue microarrays. J Natl Cancer Inst 1999;91:1758-64.
    • (1999) J. Natl. Cancer Inst. , vol.91 , pp. 1758-1764
    • Bubendorf, L.1    Kolmer, M.2    Kononen, J.3
  • 16
    • 0035874995 scopus 로고    scopus 로고
    • Human prostate cancer and benign prostatic hyperplasia: Molecular dissection by gene expression profiling
    • Luo J, Duggan DJ, Chen Y, et al. Human prostate cancer and benign prostatic hyperplasia: molecular dissection by gene expression profiling. Cancer Res 2001;61:4683-8.
    • (2001) Cancer Res. , vol.61 , pp. 4683-4688
    • Luo, J.1    Duggan, D.J.2    Chen, Y.3
  • 17
    • 0035881732 scopus 로고    scopus 로고
    • Analysis of gene expression identifies candidate markers and pharmacological targets in prostate cancer
    • Welsh JB, Sapinoso LM, Su AI, et al. Analysis of gene expression identifies candidate markers and pharmacological targets in prostate cancer. Cancer Res 2001;61:5974-8.
    • (2001) Cancer Res. , vol.61 , pp. 5974-5978
    • Welsh, J.B.1    Sapinoso, L.M.2    Su, A.I.3
  • 18
    • 0347357903 scopus 로고    scopus 로고
    • Looking beyond morphology: Cancer gene expression profiling using DNA microarrays
    • Luo J, Isaacs WB, Trent JM, Duggan DJ. Looking beyond morphology: cancer gene expression profiling using DNA microarrays. Cancer Invest 2003;21:937-49.
    • (2003) Cancer Invest. , vol.21 , pp. 937-949
    • Luo, J.1    Isaacs, W.B.2    Trent, J.M.3    Duggan, D.J.4
  • 19
    • 0141506941 scopus 로고    scopus 로고
    • Expression of the zinc transporter ZnT4 is decreased in the progression from early prostate disease to invasive prostate cancer
    • Henshall SM, Afar DE, Rasiah KK, et al. Expression of the zinc transporter ZnT4 is decreased in the progression from early prostate disease to invasive prostate cancer. Oncogene 2003;22:6005-12.
    • (2003) Oncogene , vol.22 , pp. 6005-6012
    • Henshall, S.M.1    Afar, D.E.2    Rasiah, K.K.3
  • 20
    • 18144435003 scopus 로고    scopus 로고
    • Identification and characterization of TMEFF2, a novel survival factor for hippocampal and mesencephalic neurons
    • Horie M, Mitsumoto Y, Kyushiki H, et al. Identification and characterization of TMEFF2, a novel survival factor for hippocampal and mesencephalic neurons. Genomics 2000;67:146-52.
    • (2000) Genomics , vol.67 , pp. 146-152
    • Horie, M.1    Mitsumoto, Y.2    Kyushiki, H.3
  • 21
    • 0033590080 scopus 로고    scopus 로고
    • A novel epidermal growth factor-like molecule containing two follistatin modules stimulates tyrosine phosphorylation of erbB-4 in MKN28 gastric cancer cells
    • Uchida T, Wada K, Akamatsu T, et al. A novel epidermal growth factor-like molecule containing two follistatin modules stimulates tyrosine phosphorylation of erbB-4 in MKN28 gastric cancer cells. Biochem Biophys Res Commun 1999;266:593-602.
    • (1999) Biochem. Biophys. Res. Commun. , vol.266 , pp. 593-602
    • Uchida, T.1    Wada, K.2    Akamatsu, T.3
  • 22
    • 0034282986 scopus 로고    scopus 로고
    • The gene for a novel transmembrane protein containing epidermal growth factor and follistatin domains is frequently hypermethylated in human tumor cells
    • Liang G, Robertson KD, Talmadge C, Sumegi J, Jones PA. The gene for a novel transmembrane protein containing epidermal growth factor and follistatin domains is frequently hypermethylated in human tumor cells. Cancer Res 2000;60:4907-12.
    • (2000) Cancer Res. , vol.60 , pp. 4907-4912
    • Liang, G.1    Robertson, K.D.2    Talmadge, C.3    Sumegi, J.4    Jones, P.A.5
  • 23
    • 0035888159 scopus 로고    scopus 로고
    • TENB2, a proteoglycan identified in prostate cancer that is associated with disease progression and androgen independence
    • Glynne-Jones E, Harper ME, Seery LT, et al. TENB2, a proteoglycan identified in prostate cancer that is associated with disease progression and androgen independence. Int J Cancer 2001;94:178-84.
    • (2001) Int. J. Cancer , vol.94 , pp. 178-184
    • Glynne-Jones, E.1    Harper, M.E.2    Seery, L.T.3
  • 24
    • 0042674136 scopus 로고    scopus 로고
    • Survival analysis of genome-wide gene expression profiles of prostate cancers identifies new prognostic targets of disease relapse
    • Henshall SM, Afar DE, Hiller J, et al. Survival analysis of genome-wide gene expression profiles of prostate cancers identifies new prognostic targets of disease relapse. Cancer Res 2003;63:4196-203.
    • (2003) Cancer Res. , vol.63 , pp. 4196-4203
    • Henshall, S.M.1    Afar, D.E.2    Hiller, J.3
  • 25
    • 0004032583 scopus 로고
    • Sequences of proteins of immunological interest
    • 5th ed. Washington (DC): U.S. Department of Health and Human Services, NIH
    • Kabat EA, Wu TT, Perry HM, Gottesman KS, Foeller C. Sequences of proteins of immunological interest. 5th ed. Washington (DC): U.S. Department of Health and Human Services, NIH; 1991.
    • (1991)
    • Kabat, E.A.1    Wu, T.T.2    Perry, H.M.3    Gottesman, K.S.4    Foeller, C.5
  • 26
    • 0024815233 scopus 로고
    • A humanized antibody that binds to the interleukin 2 receptor
    • Queen C, Schneider WP, Selick HE, et al. A humanized antibody that binds to the interleukin 2 receptor. Proc Natl Acad Sci USA 1989;86: 10029-33.
    • (1989) Proc. Natl. Acad. Sci. USA , vol.86 , pp. 10029-10033
    • Queen, C.1    Schneider, W.P.2    Selick, H.E.3
  • 27
    • 0032694334 scopus 로고    scopus 로고
    • Immunoglobulin VH gene expression in human aging
    • Wang X, Stollar BD. Immunoglobulin VH gene expression in human aging. Clin Immunol 1999;93:132-42.
    • (1999) Clin. Immunol. , vol.93 , pp. 132-142
    • Wang, X.1    Stollar, B.D.2
  • 28
    • 0034650994 scopus 로고    scopus 로고
    • Human antibodies with specificity for the C2 domain of factor VIII are derived from VH1 germline genes
    • van Den Brink EN, Turenhout EA, Davies J, et al. Human antibodies with specificity for the C2 domain of factor VIII are derived from VH1 germline genes. Blood 2000;95:558-63.
    • (2000) Blood , vol.95 , pp. 558-563
    • van Den Brink, E.N.1    Turenhout, E.A.2    Davies, J.3
  • 29
    • 0028784138 scopus 로고
    • Single-step assembly of a gene and entire plasmid from large numbers of oligodeoxyribonucleotides
    • Stemmer WP, Crameri A, Ha KD, Brennan TM, Heyneker HL. Single-step assembly of a gene and entire plasmid from large numbers of oligodeoxyribonucleotides. Gene 1995;164:49-53.
    • (1995) Gene , vol.164 , pp. 49-53
    • Stemmer, W.P.1    Crameri, A.2    Ha, K.D.3    Brennan, T.M.4    Heyneker, H.L.5
  • 30
    • 0031822837 scopus 로고    scopus 로고
    • Tissue microarrays for high-throughput molecular profiling of tumor specimens
    • Kononen J, Bubendorf L, Kallioniemi A, et al. Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat Med 1998; 4:844-7.
    • (1998) Nat. Med. , vol.4 , pp. 844-847
    • Kononen, J.1    Bubendorf, L.2    Kallioniemi, A.3
  • 33
    • 0035101380 scopus 로고    scopus 로고
    • The control of prostate-specific antigen expression and gene regulation by pharmacological agents
    • Dixon SC, Knopf KB, Figg WD. The control of prostate-specific antigen expression and gene regulation by pharmacological agents. Pharmacol Rev 2001;53:73-91.
    • (2001) Pharmacol. Rev. , vol.53 , pp. 73-91
    • Dixon, S.C.1    Knopf, K.B.2    Figg, W.D.3
  • 34
    • 0035793108 scopus 로고    scopus 로고
    • HPP1: A transmembrane protein-encoding gene commonly methylated in colorectal polyps and cancers
    • Young J, Biden KG, Simms LA, et al. HPP1: a transmembrane protein-encoding gene commonly methylated in colorectal polyps and cancers. Proc Natl Acad Sci USA 2001;98:265-70.
    • (2001) Proc. Natl. Acad. Sci. USA , vol.98 , pp. 265-270
    • Young, J.1    Biden, K.G.2    Simms, L.A.3
  • 35
    • 0037130470 scopus 로고    scopus 로고
    • TMEFF2 is an androgen-regulated gene exhibiting anti proliferative effects in prostate cancer cells
    • Gary S, Sawyers CL, Agus DB, Said JW, Koeffler HP. TMEFF2 is an androgen-regulated gene exhibiting anti proliferative effects in prostate cancer cells. Oncogene 2002;21:4739-46.
    • (2002) Oncogene , vol.21 , pp. 4739-4746
    • Gary, S.1    Sawyers, C.L.2    Agus, D.B.3    Said, J.W.4    Koeffler, H.P.5
  • 36
    • 0036604401 scopus 로고    scopus 로고
    • Identification of differentially expressed genes associated with androgen-independent growth of prostate cancer
    • Mohler JL, Morris TL, Ford OH III, Alvey RF, Sakamoto C, Gregory CW. Identification of differentially expressed genes associated with androgen-independent growth of prostate cancer. Prostate 2002;51: 247-55.
    • (2002) Prostate , vol.51 , pp. 247-255
    • Mohler, J.L.1    Morris, T.L.2    Ford III, O.H.3    Alvey, R.F.4    Sakamoto, C.5    Gregory, C.W.6
  • 37
    • 0026418194 scopus 로고
    • Humanized antibodies for therapy
    • Co MS, Queen C. Humanized antibodies for therapy. Nature 1991; 351:501-2.
    • (1991) Nature , vol.351 , pp. 501-502
    • Co, M.S.1    Queen, C.2
  • 38
    • 0029063667 scopus 로고
    • Eradication of large human B cell tumors in nude mice with unconjugated CD20 monoclonal antibodies and interleukin 2
    • Hooijberg E, Sein JJ, van den Berk PC, et al. Eradication of large human B cell tumors in nude mice with unconjugated CD20 monoclonal antibodies and interleukin 2. Cancer Res 1995;55:2627-34.
    • (1995) Cancer Res. , vol.55 , pp. 2627-2634
    • Hooijberg, E.1    Sein, J.J.2    van den Berk, P.C.3
  • 39
    • 0031031895 scopus 로고    scopus 로고
    • Effect of linker variation on the stability, potency, and efficacy of carcinoma-reactive BR64-doxorubicin immunoconjugates
    • Trail PA, Willner D, Knipe J, et al. Effect of linker variation on the stability, potency, and efficacy of carcinoma-reactive BR64-doxorubicin immunoconjugates. Cancer Res 1997;57:100-5.
    • (1997) Cancer Res. , vol.57 , pp. 100-105
    • Trail, P.A.1    Willner, D.2    Knipe, J.3
  • 40
    • 0742287749 scopus 로고    scopus 로고
    • Radioimmunotherapy of prostate cancer in human xenografts using monoclonal antibodies specific to prostate specific membrane antigen (PSMA): Studies in nude mice
    • Vallabhajosula S, Smith-Jones PM, Navarro V, Goldsmith SJ, Bander NH. Radioimmunotherapy of prostate cancer in human xenografts using monoclonal antibodies specific to prostate specific membrane antigen (PSMA): studies in nude mice. Prostate 2004;58:145-55.
    • (2004) Prostate , vol.58 , pp. 145-155
    • Vallabhajosula, S.1    Smith-Jones, P.M.2    Navarro, V.3    Goldsmith, S.J.4    Bander, N.H.5
  • 41
    • 0035977710 scopus 로고    scopus 로고
    • Expression of TMEFF1 mRNA in the mouse central nervous system: Precise examination and comparative studies of TMEFF1 and TMEFF2
    • Kanemoto N, Horie M, Omori K, et al. Expression of TMEFF1 mRNA in the mouse central nervous system: precise examination and comparative studies of TMEFF1 and TMEFF2. Brain Res Mol Brain Res 2001;86: 48-55.
    • (2001) Brain Res. Mol. Brain Res. , vol.86 , pp. 48-55
    • Kanemoto, N.1    Horie, M.2    Omori, K.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.